Traws Pharma
Price & Volume
Stats
See moreOpen | $1.88 |
Previous Close | $1.85 |
Day Range | $1.88-$1.92 |
52W Range | $0.97-$15 |
Market Cap | $13.3M |
Shares Short | 119,973 |
Financials
See moreRevenue (12 Mos) | $2.9M |
Revenue Growth (YoY) | 4,694.7% |
Gross Profit (12 Mos) | $2.9M |
Diluted EPS | $4.28 |
News
See moreYahoo Finance • 12 hours ago
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
Yahoo Finance • 7 days ago
Annovis Appoints Mark Guerin as Chief Financial Officer
Yahoo Finance • last month
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
Yahoo Finance • 2 months ago
Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
About
CEO | Dr. Iain D. Dukes DPHIL, M.A., Ph.D. |
Address | 12 Penns Trail, Newtown, PA, United States, 18940 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
